FDA — authorised 10 November 1982
- Marketing authorisation holder: CHART MEDCL
- Status: approved
🇺🇸 Discase in United States
FDA authorised Discase on 10 November 1982
Marketing authorisations
FDA — authorised 10 November 1982
- Application: BLA018663
- Marketing authorisation holder: DISCURE MEDICAL, LLC
- Local brand name: CHYMODIACTIN
- Indication: INJECTABLE — INJECTION
- Status: approved
Discase in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is Discase approved in United States?
Yes. FDA authorised it on 10 November 1982; FDA authorised it on 10 November 1982.
Who is the marketing authorisation holder for Discase in United States?
CHART MEDCL holds the US marketing authorisation.